197 related articles for article (PubMed ID: 31263798)
1. An omentum-inspired 3D PEG hydrogel for identifying ECM-drivers of drug resistant ovarian cancer.
Brooks EA; Gencoglu MF; Corbett DC; Stevens KR; Peyton SR
APL Bioeng; 2019 Jun; 3(2):026106. PubMed ID: 31263798
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional culture and clinical drug responses of a highly metastatic human ovarian cancer HO-8910PM cells in nanofibrous microenvironments of three hydrogel biomaterials.
Song H; Cai GH; Liang J; Ao DS; Wang H; Yang ZH
J Nanobiotechnology; 2020 Jun; 18(1):90. PubMed ID: 32527266
[TBL] [Abstract][Full Text] [Related]
3. A multicellular 3D heterospheroid model of liver tumor and stromal cells in collagen gel for anti-cancer drug testing.
Yip D; Cho CH
Biochem Biophys Res Commun; 2013 Apr; 433(3):327-32. PubMed ID: 23501105
[TBL] [Abstract][Full Text] [Related]
4. Comparative Study of Multicellular Tumor Spheroid Formation Methods and Implications for Drug Screening.
Gencoglu MF; Barney LE; Hall CL; Brooks EA; Schwartz AD; Corbett DC; Stevens KR; Peyton SR
ACS Biomater Sci Eng; 2018 Feb; 4(2):410-420. PubMed ID: 29527571
[TBL] [Abstract][Full Text] [Related]
5. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells.
Loessner D; Stok KS; Lutolf MP; Hutmacher DW; Clements JA; Rizzi SC
Biomaterials; 2010 Nov; 31(32):8494-506. PubMed ID: 20709389
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays.
Tofani LB; Abriata JP; Luiz MT; Marchetti JM; Swiech K
Biotechnol Prog; 2020 Nov; 36(6):e3034. PubMed ID: 32519461
[TBL] [Abstract][Full Text] [Related]
7. Hydrogel matrix presence and composition influence drug responses of encapsulated glioblastoma spheroids.
Hill L; Bruns J; Zustiak SP
Acta Biomater; 2021 Sep; 132():437-447. PubMed ID: 34010694
[TBL] [Abstract][Full Text] [Related]
8. Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties.
Hirst J; Pathak HB; Hyter S; Pessetto ZY; Ly T; Graw S; Koestler DC; Krieg AJ; Roby KF; Godwin AK
Cancer Res; 2018 Aug; 78(15):4370-4385. PubMed ID: 29891506
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment.
Dong Y; Stephens C; Walpole C; Swedberg JE; Boyle GM; Parsons PG; McGuckin MA; Harris JM; Clements JA
PLoS One; 2013; 8(2):e57056. PubMed ID: 23451143
[TBL] [Abstract][Full Text] [Related]
10. Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance.
Borghese C; Casagrande N; Corona G; Aldinucci D
Pharmaceutics; 2020 Apr; 12(5):. PubMed ID: 32349462
[TBL] [Abstract][Full Text] [Related]
11. In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and Paclitaxel.
Casagrande N; Borghese C; Agostini F; Durante C; Mazzucato M; Colombatti A; Aldinucci D
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809553
[TBL] [Abstract][Full Text] [Related]
12. Efficient fabrication of monodisperse hepatocyte spheroids and encapsulation in hybrid hydrogel with controllable extracellular matrix effect.
Deng S; Zhu Y; Zhao X; Chen J; Tuan RS; Chan HF
Biofabrication; 2021 Oct; 14(1):. PubMed ID: 34587587
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interplay between human MSCs and HUVECs in 3D spheroids laden in collagen/fibrin hydrogels for bone tissue engineering.
Heo DN; Hospodiuk M; Ozbolat IT
Acta Biomater; 2019 Sep; 95():348-356. PubMed ID: 30831326
[TBL] [Abstract][Full Text] [Related]
14. In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening.
Antunes J; Gaspar VM; Ferreira L; Monteiro M; Henrique R; Jerónimo C; Mano JF
Acta Biomater; 2019 Aug; 94():392-409. PubMed ID: 31200118
[TBL] [Abstract][Full Text] [Related]
15. Natural and Synthetic Biomaterials for Engineering Multicellular Tumor Spheroids.
Kamatar A; Gunay G; Acar H
Polymers (Basel); 2020 Oct; 12(11):. PubMed ID: 33126468
[TBL] [Abstract][Full Text] [Related]
16. Electrostatic Assembly of Multiarm PEG-Based Hydrogels as Extracellular Matrix Mimics: Cell Response in the Presence and Absence of RGD Cell Adhesive Ligands.
Suwannakot P; Nemec S; Peres NG; Du EY; Kilian KA; Gaus K; Kavallaris M; Gooding JJ
ACS Biomater Sci Eng; 2023 Mar; 9(3):1362-1376. PubMed ID: 36826383
[TBL] [Abstract][Full Text] [Related]
17. 3D bioprinted drug-resistant breast cancer spheroids for quantitative in situ evaluation of drug resistance.
Hong S; Song JM
Acta Biomater; 2022 Jan; 138():228-239. PubMed ID: 34718182
[TBL] [Abstract][Full Text] [Related]
18. Hybrid collagen alginate hydrogel as a platform for 3D tumor spheroid invasion.
Liu C; Lewin Mejia D; Chiang B; Luker KE; Luker GD
Acta Biomater; 2018 Jul; 75():213-225. PubMed ID: 29879553
[TBL] [Abstract][Full Text] [Related]
19. Generation of a Three-Dimensional in Vitro Ovarian Cancer Co-Culture Model for Drug Screening Assays.
Tofani LB; Sousa LO; Luiz MT; Abriata JP; Marchetti JM; Leopoldino AM; Swiech K
J Pharm Sci; 2021 Jul; 110(7):2629-2636. PubMed ID: 33848527
[TBL] [Abstract][Full Text] [Related]
20. A three-dimensional spheroidal cancer model based on PEG-fibrinogen hydrogel microspheres.
Pradhan S; Clary JM; Seliktar D; Lipke EA
Biomaterials; 2017 Jan; 115():141-154. PubMed ID: 27889665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
